
CAS 1797989-42-4
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte.
6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile hydrochloride
CAS:Reinheit:98%Molekulargewicht:501.7999878CHIR-99021 Hydrochloride
CAS:<p>Applications CHIR-99021 is a potent and highly selective inhibitor of glycogen synthase kinase 3 (GSK-3). CHIR-99021 activates glycogen synthesis in CHO-IR cells and in isolated type 1 diabetic rat skeletal muscle. CHIR-99021 has also been shown to induce the reprogramming of murine and human somatic cells into stem cells. GSK-3α/β inhibitor<br>References Ring, et al.: Diabetes, 52, 588 (2003); Tighe, et al.: Cell Biol., 8, 34 (2007); Pan, et al.: Neuropsychopharmacology, 36, 1397 (2011);<br></p>Formel:C22H19Cl3N8Farbe und Form:NeatMolekulargewicht:501.8CHIR 99021 hydrochloride
CAS:<p>Potent and selective inhibitor of the glycogen synthase kinase GSK-3. Promotes cell renewal in embryonic stem cells by modulating Notch, MAPK and TGF-β signalling pathways, which are involved in pluripotency. It also affects the Wnt/β-catenin pathway and alters expression of genes coding for proteins, epigenetic regulatory elements and non-coding RNAs. The combination of CHIR 99021 and basic fibroblast growth factor (bFGF) allows long-term self-renewal in adult mouse retinal progenitor cells.</p>Formel:C22H18Cl2N8·HClReinheit:Min. 95%Molekulargewicht:501.8 g/molCHIR-99021 HCl
CAS:CHIR-99021 HCl is a selective GSK-3α/β inhibitor (IC50: 10/6.7 nM), 500x selective over other kinases, boosts Wnt pathway, and enhances stem cell renewal.Formel:C22H19Cl3N8Reinheit:98.07% - 98.14%Farbe und Form:SolidMolekulargewicht:501.8Ref: TM-T2310L
1mg35,00€2mg52,00€5mg77,00€10mg96,00€25mg163,00€50mg240,00€100mg465,00€200mg675,00€500mg1.026,00€1mL*10mM (DMSO)86,00€




